/
NIVF
$0.53-$0.04 (-7.38%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$5.6M
10M shares
52-week range
$0.47 – $372.00
0% from low
Exchange
NASDAQ
CS
Borrow rate
133.53%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-89999.48
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $4.1M | $5.9M | $5.1M | $5.4M | $4.7M |
| Cost of revenue | $3.1M | $4.4M | $3.5M | $3.6M | $3.8M |
| Gross profit | $1.0M | $1.5M | $1.7M | $1.8M | $955.8K |
| Gross margin | 24.9% | 25.9% | 32.7% | 33.6% | 20.2% |
| R&D | $0 | $0 | $0 | $0 | $0 |
| Operating income | $198.8K | −$504.9K | $42.2K | −$1.2M | −$10.7M |
| EBITDA | $587.0K | $725.7K | $384.3K | $24.3K | $10.8M |
| Net income | −$533 | $458.7K | $130.2K | −$525.0K | $9.9M |
| Net margin | -0.0% | 7.7% | 2.5% | -9.7% | 209.0% |
| EPS (diluted) | -0.00 | 62.52 | 12.44 | -22.31 | 16.80 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $65M | $4.74 | $4.74–$4.74 | 1 |
| 2027 | $180M | $9.34 | $9.34–$9.34 | 1 |
| 2028 | $271M | $14.70 | $14.70–$14.70 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
NewGenIvf Group Limited Class A ordinary shares
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
www.nivf.global- Employees
- 87
- IPO / List date
- Apr 4, 2024
Held by traders on TradeandTell
No one on the platform currently holds NIVF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in NIVF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-03-16 | 1-for-4reverse |
| 2026-01-26 | 1-for-3reverse |
| 2025-12-01 | 1-for-5reverse |
| 2025-08-04 | 1-for-5reverse |
| 2025-05-05 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded NIVF yet.
